Cargando…

Perspective: Collagen induced platelet activation via the GPVI receptor as a primary target of colchicine in cardiovascular disease

Colchicine has been demonstrated to reduce cardiovascular death, myocardial infarction (MI), ischemic stroke, and ischemia-driven coronary revascularization in people with coronary artery disease (CAD). These reductions were observed even in patients already taking antiplatelet therapy. As well as h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pennings, Gabrielle J., Reddel, Caroline J., Chen, Vivien M., Gnanenthiran, Sonali R., Kritharides, Leonard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892722/ https://www.ncbi.nlm.nih.gov/pubmed/36741844 http://dx.doi.org/10.3389/fcvm.2022.1104744

Ejemplares similares

Colchicine inhibits ROS generation in response to glycoprotein VI stimulation
por: Pennings, G. J., et al.
Publicado: (2021)

Clustering of glycoprotein VI (GPVI) dimers upon adhesion to collagen as a mechanism to regulate GPVI signaling in platelets
por: Poulter, N. S., et al.
Publicado: (2017)

Antiplatelet Activity of Tussilagone via Inhibition of the GPVI Downstream Signaling Pathway in Platelets
por: Zhou, Jing, et al.
Publicado: (2020)

Association between pre-existing cardiovascular disease, mortality and cardiovascular outcomes in hospitalised patients with COVID-19
por: Sritharan, Hari P., et al.
Publicado: (2023)

Tetraspanin Tspan9 regulates platelet collagen receptor GPVI lateral diffusion and activation
por: Haining, Elizabeth J., et al.
Publicado: (2016)

Evaluation of the effect of eltrombopag therapy on the platelet collagen receptor glycoprotein VI (GPVI) expression and soluble GPVI levels in young patients with immune thrombocytopenia
por: Tantawy, Azza Abdel Gawad, et al.
Publicado: (2022)

Anti‐GPVI nanobody blocks collagen‐ and atherosclerotic plaque–induced GPVI clustering, signaling, and thrombus formation
por: Jooss, Natalie J., et al.
Publicado: (2022)

Do bisphosphonates and RANKL inhibitors alter the progression of coronary artery calcification? A systematic review and meta-analysis protocol
por: Saunders, Samantha Louise, et al.
Publicado: (2022)

Colchicine for Coronary Artery Disease: A Review
por: Chen, Tao, et al.
Publicado: (2022)

GPVI expression is linked to platelet size, age, and reactivity
por: Veninga, Alicia, et al.
Publicado: (2022)

Procoagulant platelet sentinels prevent inflammatory bleeding through GPIIBIIIA and GPVI
por: Kaiser, Rainer, et al.
Publicado: (2022)

Constitutive Dimerization of Glycoprotein VI (GPVI) in Resting Platelets Is Essential for Binding to Collagen and Activation in Flowing Blood
por: Jung, Stephanie M., et al.
Publicado: (2012)

Chronic occlusion of the thoracic aorta: a novel cause of pleuropericardial effusions and pancytopenia
por: Gnanenthiran, Sonali R., et al.
Publicado: (2021)

mTOR regulates GPVI-mediated platelet activation
por: Wang, Longsheng, et al.
Publicado: (2021)

Identification of Tspan9 as a novel platelet tetraspanin and the collagen receptor GPVI as a component of tetraspanin microdomains
por: Protty, Majd B., et al.
Publicado: (2008)

Human Platelet Protein Ubiquitylation and Changes following GPVI Activation
por: Unsworth, Amanda J., et al.
Publicado: (2019)

Platelet-Derived Microvesicles in Cardiovascular Diseases
por: Zaldivia, Maria T. K., et al.
Publicado: (2017)

Gene Targeting Implicates Cdc42 GTPase in GPVI and Non-GPVI Mediated Platelet Filopodia Formation, Secretion and Aggregation
por: Akbar, Huzoor, et al.
Publicado: (2011)

Colchicine for the Treatment of Cardiac Injury in Hospitalized Patients With Coronavirus Disease-19
por: Rabbani, Amir, et al.
Publicado: (2022)

Soluble Platelet Release Factors as Biomarkers for Cardiovascular Disease
por: Baidildinova, Gaukhar, et al.
Publicado: (2021)

Early long-term low-dosage colchicine and major adverse cardiovascular events in patients with acute myocardial infarction: a systematic review and meta-analysis
por: Zhou, Yifang, et al.
Publicado: (2023)

A Meta-Analysis Evaluating the Colchicine Therapy in Patients With Coronary Artery Disease
por: Grajek, Stefan, et al.
Publicado: (2021)

Rac Inhibition Causes Impaired GPVI Signalling in Human Platelets through GPVI Shedding and Reduction in PLCγ2 Phosphorylation
por: Neagoe, Raluca A. I., et al.
Publicado: (2022)

Platelet GPVI (Glycoprotein VI) and Thrombotic Complications in the Venous System
por: Perrella, Gina, et al.
Publicado: (2021)

Targeting platelet GPVI with glenzocimab: a novel mechanism for inhibition
por: Billiald, Philippe, et al.
Publicado: (2022)

Editorial: Role of the Platelet Phenomenon in Cardiovascular Diseases and Cancer
por: Panova-Noeva, Marina, et al.
Publicado: (2022)

Colchicine for prevention of post-operative atrial fibrillation: Meta-analysis of randomized controlled trials
por: Ge, Peibing, et al.
Publicado: (2022)

The Platelet Collagen Receptor GPVI Is Cleaved by Tspan15/ADAM10 and Tspan33/ADAM10 Molecular Scissors
por: Koo, Chek Ziu, et al.
Publicado: (2022)

Differential Inhibition of Human Atherosclerotic Plaque–Induced Platelet Activation by Dimeric GPVI-Fc and Anti-GPVI Antibodies: Functional and Imaging Studies
por: Jamasbi, Janina, et al.
Publicado: (2015)

Colchicine and coronary heart disease risks: A meta-analysis of randomized controlled clinical trials
por: Ma, Zijun, et al.
Publicado: (2022)

Neutrophil-Platelet Interactions as Novel Treatment Targets in Cardiovascular Disease
por: Kaiser, Rainer, et al.
Publicado: (2022)

Differential roles for the adapters Gads and LAT in platelet activation by GPVI and CLEC-2
por: HUGHES, C E, et al.
Publicado: (2008)

Biobanking for discovery of novel cardiovascular biomarkers using imaging-quantified disease burden: protocol for the longitudinal, prospective, BioHEART-CT cohort study
por: Kott, Katharine A, et al.
Publicado: (2019)

Evaluation of low-dose colchicine in patients with cardiopulmonary bypass: study protocol for a randomised controlled trial
por: Zhang, He, et al.
Publicado: (2022)

Dynamin 2 is required for GPVI signaling and platelet hemostatic function in mice
por: Eaton, Nathan, et al.
Publicado: (2020)

Luteolin inhibits GPVI-mediated platelet activation, oxidative stress, and thrombosis
por: Ye, Yujia, et al.
Publicado: (2023)

Cross-Linking GPVI-Fc by Anti-Fc Antibodies Potentiates Its Inhibition of Atherosclerotic Plaque- and Collagen-Induced Platelet Activation
por: Jamasbi, Janina, et al.
Publicado: (2016)

Colchicine and diabetes in patients with chronic coronary artery disease: insights from the LoDoCo2 randomized controlled trial
por: Mohammadnia, Niekbachsh, et al.
Publicado: (2023)

Efficacy and Safety of Colchicine in Post–acute Myocardial Infarction Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Diaz-Arocutipa, Carlos, et al.
Publicado: (2021)

Identification of a major GpVI-binding locus in human type III collagen
por: Jarvis, Gavin E., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_9ood3qv8uve2stomj6bse599jh